Clinical Trials Directory

Trials / Sponsors / TWi Biotechnology, Inc.

TWi Biotechnology, Inc.

Industry · 10 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingAn International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study W
Generalized Epidermolysis Bullosa Simplex
Phase 2 / Phase 32024-04-04
CompletedStudy to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare
Granuloma Annulare
Phase 12022-10-03
CompletedTofacitinib Citrate Topical Gel 3.2% FDA BA Bridging Study
Healthy Subjects
Phase 12020-10-14
CompletedProphylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy
EGFR Inhibitor-Induced Skin Rash
Phase 22019-10-02
CompletedA Double-blind, Intra-individual Comparison, POC Trial of AC-203 in EB Patients
Inherited Epidermolysis Bullosa
Phase 22018-10-20
TerminatedA Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid
Bullous Pemphigoid
Phase 22017-09-05
CompletedA Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropat
Hemophilic Arthropathy
Phase 22017-03-21
CompletedA Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
Gout
Phase 22014-12-01
CompletedA Proof-of-Concept Study of AC-201 to Prevent Gout Flares
Gout Flares
Phase 22013-01-01
CompletedStudy of AC-201 in Patients With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 22011-01-01